A small Boston biotech is at the heart of a groundbreaking approach to tackling cancer
• Agios Pharmaceuticals, a company that got its start less than a decade ago, already has one drug in front of the FDA.• The company makes drugs that essentially try to repair cancer cells so they can grow old.• If the drug's approved, it could be the first to target the metabolism of cancer cells, a …
Read more on businessinsider.com
Business Insider flipped this story into Latest Stories•2523d